title: Significance of soluble interleukin-2 receptor in patients with hemophagocytic lymphohistiocytosis.
authors.forename: Lijuan
authors.initials: L
authors.lastname: Zhang
authors.forename: Sujiang
authors.initials: S
authors.lastname: Zhang
authors.forename: Ji
authors.initials: J
authors.lastname: Xu
authors.forename: Yixin
authors.initials: Y
authors.lastname: Hu
authors.forename: Lingling
authors.initials: L
authors.lastname: Wang
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Zhang
authors.forename: Wei
authors.initials: W
authors.lastname: Xu
authors.forename: Peng
authors.initials: P
authors.lastname: Liu
authors.forename: Hongxia
authors.initials: H
authors.lastname: Qiu
authors.forename: Jianyong
authors.initials: J
authors.lastname: Li
mesh_terms: D006801:Humans; D053645:Interleukin-2 Receptor alpha Subunit / Q000097:blood*; D053208:Kaplan-Meier Estimate; D051359:Lymphohistiocytosis, Hemophagocytic / Q000097:blood* / Q000175:diagnosis / Q000401:mortality; D011379:Prognosis; D012995:Solubility
chemical_list: D053645:Interleukin-2 Receptor alpha Subunit